The Correction, in vitro, of Lysosomal Enzyme Deficiencies by Means of Immunoglobulin-Coated Liposomes

  • Gerald Weissmann
  • Charles Cohen
  • Sylvia Hoffstein
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 68)


In 1965, we described, with A. D. Bangham (1) the formation of artificial lipid structures which could serve as models for the membranes of cells and/or organelles. By 1968 (2), we had coined the term “liposome” to describe these artificial, multilamellar structures, which, in their response to steroids, lytic proteins, polyene antibiotics, etc. closely resembled natural biomembranes. (The term “liposome” has now been generally accepted). Yet it was not until 1970 (3) that it became possible to encapsulate an enzyme, rather than low molecular weight solutes such as ions, glucose or dyes, into the aqueous interstices between the multilamellar lipid bilayers of liposomes. We utilized the enzyme lysozyme and established its mode of trapping in the following fashion: Gel filtration resolved liposomes formed in the absence of enzyme from free enzyme when both were chromatographed immediately after mixing. In contrast, if liposomes were permitted to form in the presence of lysozyme, subsequent chromatography disclosed two peaks of enzyme activity: one associated with liposomes, the other emerging as free lysozyme. The activity of lysozyme associated with liposomes was “latent” i.e. there was little or no activity on substrate unless the liposomes were disrupted by Triton X-100, amphotericin B, or nystatin.


Enzyme Replacement Therapy Lysosomal Enzyme Polymorphonuclear Leukocyte Free Enzyme Enzyme Release 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bangham, A.D., Standish, M.M. and Weissmann, G. (1965) J. Mol. Biol. 13: 253–259.PubMedCrossRefGoogle Scholar
  2. 2.
    Sessa, G. and Weissmann, G. (1968) J. Lipid Res. 9: 310–318.PubMedGoogle Scholar
  3. 3.
    Sessa, G. and Weissmann, G. (1970) J. Biol. Chem. 245: 325–3301.Google Scholar
  4. 4.
    Rahman, Y.E. (1974) Proc. Soc. Exp. Biol. & Med. 145: 1173.Google Scholar
  5. 5.
    Colley, C.M. and Ryman, B.E. (1975) Biochem. Soc. Trans. 3: 157.PubMedGoogle Scholar
  6. 6.
    Rahman, Y.E., Rosenthal, M.W. and Cerny, E.A. (1973) Science. 180: 300.PubMedCrossRefGoogle Scholar
  7. 7.
    Gregoriadis. G. in “Enzyme Therapy in Lysosomal Storage Diseases” (eds. J.M. Tager, G.J.M. Hoogwinkel and W. Th. Daems) North-Holland Publishing, Amsterdam, p. 131, 1974.Google Scholar
  8. 8.
    Ryman, B.E. in “Enzyme Therapy in Lysosomal Storage Diseases” (eds. J.M. Tager, G.J.M. Hoogwinkel and W. Th. Daems) North-Holland Publishing, Amsterdam, p. 149, 1974.Google Scholar
  9. 9.
    Gregoriadis, G. and Allison, A.C. (1974) FEBS Letters 45: 71.PubMedCrossRefGoogle Scholar
  10. 10.
    Straub, S.X., Garry, R.F. and Magee, W.E. (1974) Infect.Immun. 10: 783.PubMedGoogle Scholar
  11. 11.
    McDougall, I.R., Dunnick, J.K., McNamee, M.G. and Kriss, J. P. (1974) Proc. Natl. Acad. Sci. (U.S.) 71: 3487.CrossRefGoogle Scholar
  12. 12.
    Segal, A.W., Wills, E.J., Richmond, J.E., Slavin, G., Black, C.D.V. and Gregoriadis, G. (1974) Brit. J. Exp. Path. 55: 320.PubMedGoogle Scholar
  13. 13.
    Pagano, R.E., Huang, L. and Wey, C. (1974) Nature 242: 166–167.CrossRefGoogle Scholar
  14. 14.
    Sessa, G. and Weissmann, G. (1969) J. Clin. Invest. 48: 77a.Google Scholar
  15. 15.
    Magee, W.E. and Miller, O. (1972) Nature 235: 339–341.PubMedCrossRefGoogle Scholar
  16. 16.
    Papahadjopoulos, D., Poste, G. and Schaeffer, B.E. (1973) Biochim. Biophys. Acta 323: 23–42.PubMedCrossRefGoogle Scholar
  17. 17.
    Henson, P.M., Johnson, H.B. and Spiegelberg, H.L. (1972) J. Immun. 109: 1182–1191.PubMedGoogle Scholar
  18. 18.
    Weissmann, G., Brand, A. and Franklin, E.C. (1974) J. Clin. Invest. 53: 536–543.PubMedCrossRefGoogle Scholar
  19. 19.
    Weissmann, G., Bloomgarden, D., Kaplan, R., Cohen, C., Hoffstein, S., Collins, T., Gottlieb, A. and Nagle, D. (1975) Proc. Nat. Acad. Sci. 72: 88–92.PubMedCrossRefGoogle Scholar
  20. 20.
    Lehrer, R.I. and Cline, M.J. (1969) J. Clin. Invest. 48: 1487–1496.CrossRefGoogle Scholar
  21. 21.
    Cohen, C.M., Weissmann, G., Hoffstein, S., Awasthi, Y.C. and Srivastava, S.K. (submitted to Biochemistry).Google Scholar
  22. 22.
    Zurier, R.B., Hoffstein, S. and Weissmann, G. (1973) J. Cell Biol. 58: 27–41.PubMedCrossRefGoogle Scholar
  23. 23.
    Zurier, R.B., Weissmann, G., Hoffstein, S., Kammerman, S. and Tai, H.-H. (1974) J. Clin. Invest. 53: 297–309.PubMedCrossRefGoogle Scholar
  24. 24.
    Zurier, R.B., Hoffstein, S. and Weissmann, G. (1973) Proc. Nat. Acad. Sci. 70: 844–848.PubMedCrossRefGoogle Scholar
  25. 25.
    Goldstein, I., Hoffstein, S., Gallin, J. and Weissmann, G. (1973) Proc. Nat. Acad. Sci. USA. 70: 2916–2920.PubMedCrossRefGoogle Scholar
  26. 26.
    Dunham, P.G., Goldstein, I.M. and Weissmann, G. (1974) J.Cell Biol. 63: 215–226.PubMedCrossRefGoogle Scholar
  27. 27.
    Goldstein, I.M., Roos, D., Weissmann, G., Kaplan, H. (1975) J. Clin. Invest. (in press).Google Scholar
  28. 28.
    deDuve, C.D., deBarsy, T., Poole, B., Trouet, A., Tulkens, Pa. and vanHoof, F. (1974) Biochem. Pharm. 23: 2495.CrossRefGoogle Scholar
  29. 29.
    Johnson, W.G., Desnick, R.J., Long, D.M., Sharp, H.L., Krivit, W., Brady, B. and Brady, R.O. (1973) in “Enzyme Therapy in Genetic Disease” (Bergsma, D. ed.) Vol. 9, William and Wilkins Co., Baltimore, p. 120–124.Google Scholar
  30. 30.
    Brady, R., Pentchev, P., Gal, A., Hibbert, S. and Dekaban, A. (1974) N. Engl. J. Med. 291: 989–993.PubMedCrossRefGoogle Scholar
  31. 31.
    Brady, R.O., Tallman, J.F. and Johnson, W.G. (1973) N. Engl. J. Med. 289: 9–14.PubMedCrossRefGoogle Scholar
  32. 32.
    Brady, R.O., Pentchev, P.G. and Gal, A.E. (1975) Fed. Proc. 34: 1310.PubMedGoogle Scholar
  33. 33.
    Weissmann, U.N. (1974) in “Enzyme Therapy in Lysosomal Storage Diseases” (J.M. Tager, G. Hoogwinkel and W. Th. Daems, eds.) North-Holland Co. Amsterdam, p. 85.Google Scholar
  34. 34.
    Weissmann, U.N., Rossi, E. and Herschkowitz, N. (1971) N. Engl. J. Med. 284: 672.CrossRefGoogle Scholar
  35. 35.
    Porter, M.T., Fluharty, A.L. and Kihara, H. (1971) Science 172: 1263.PubMedCrossRefGoogle Scholar
  36. 36.
    Morell, A.G., Irvine, R.A., Sternlieb, I., Scheinberg, I. and Ashwell, G. (1968) J. Biol. Chem. 243: 155–159.PubMedGoogle Scholar
  37. 37.
    Hickman, S., Shapiro, L.J. and Neufeld, E. (1974) Biochem. Biophys. Res. Comm. 57: 55–61.PubMedCrossRefGoogle Scholar
  38. 38.
    VonFigura, K. and Kresse, H. (1974) J. Clin. Invest. 53: 85–90.CrossRefGoogle Scholar
  39. 39.
    O’Brien, J.S., Miller, A.L., Loverde, A.W. and Veath, M.L. (1973) Science 181: 753–755.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1976

Authors and Affiliations

  • Gerald Weissmann
    • 1
  • Charles Cohen
    • 1
  • Sylvia Hoffstein
    • 1
  1. 1.Division of Rheumatology, Department of MedicineNew York University Medical CenterNew YorkUSA

Personalised recommendations